Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-02-24
1996-05-21
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
5303871, A61K 3816, C07K 1600
Patent
active
055190014
ABSTRACT:
A polypeptide and analogues thereof inhibit cholesteryl ester transfer protein (CETP). An anti-atherosclerosis composition comprises an anti-atherosclerosis effective amount of the polypeptide and a pharmaceutically-acceptable carrier. An anti-atherosclerosis kit comprises in separate sterile containers at least one unit of the composition containing the polypeptide, one syringe and one needle. An antibody has specificity for the polypeptide of the invention, the baboon CETP 4 kD polypeptide inhibitor, the 1-36 amino acid N-terminal fragment of apo C-I, modified apo A-I (MW: 31 kD) or modified apo E (MW: 41 kD). A method of preventing atherosclerosis in a mammal being predisposed to that condition comprises administering to the mammal a prophylactically effective amount of the polypeptide of the invention, and a method of treating a mammal afflicted with atherosclerosis comprises the administration of a therapeutically effective amount of the polypeptide disclosed herein.
REFERENCES:
Koizumi et al., "Atherosclerosis", 58:175-186 (1985).
Yokoyama et al., "Artery" 14(1):43-51 (1986).
Kushwaha et al., "J. of Lipid Research", 31:965-973 (1990).
Son et al., "Biochimica et Biophysica Acta", 795:473-480 (1984).
Kurasawa et al., "J. Biochem." 98:1499-1508 (1985).
Albers et al., "Lipids", 9:15-26 (1974).
Kohler et al., "Nature", 256:495-497 (1975).
Williams et al., "J. of Chromatography", 308:101-109 (1984).
Kushwaha et al., "J. of Lipid Research", 27:497-507 (1986).
McGill et al., "Arteriosclerosis", 6:651-663 (1986).
Redgrave et al., "Analytical Biochem.", 65:42-49 (1975).
Allain et al., "Clin. Chem.", 20:470-475 (1974).
Laemmli "Nature", 227:680-684 (1970).
Floren et al., "Metabolism", 30:367-375 (1981).
McKinney et al., "J. of Immunological Methods", 96:271-278 (1987).
Cheung et al., "J. of Lipid Research", 23:748-753 (1982).
Barany et al., "The Peptides" 2:1-284 (1980).
Duncan, D. B., "Biometrics", pp. 1-42 (1955).
Pearson et al., "Proc. Natl. Acad. Sci." 85:2444-2448 (1988).
Krul et al., J. Lip Res., 28:818, 1987, Expression . . . lipoproteins.
Lerner et al, Adv. Immunol., 36:1, 1984, Antibodies . . . medicine.
Harlow et al., Antibodies, A Laboratory Manual, 1988, p. 287.
Kanda Patrick
Kushwaha Rampratap
McGill, Jr. Henry C.
Prickril Benet
Southwest Foundation for Biomedical Research
Warden Jill
LandOfFree
CETP inhibitor polypeptide antibodies against the synthetic poly does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CETP inhibitor polypeptide antibodies against the synthetic poly, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CETP inhibitor polypeptide antibodies against the synthetic poly will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2038088